BIR Annual Radiotherapy and Oncology meeting 2021

18th - 19th March 2021   (GMT+01:00) Europe/London

This is an inaugural meeting for the BIR, which brings together speakers from around the world and national experts too, to share experiences and expertise in a very wide range of aspects for today’s cutting-edge radiotherapy and oncology. The latest techniques, technologies, methods and issues will be discussed in this comprehensive meeting taking place over two days. Opportunities aplenty for networking with fellow professionals and discussing the latest offerings from manufacturers.
Parallel streams will be used to maximise the sessional opportunities, together with expert plenary talks from Professors Jean Bourhis (FLASH Radiotherapy), Michael Baumann (Radiation Oncology in the era of personalised medicine) and Heidi Probst.

Keynote talks will headline each session, and topic areas will include:
•    Particle therapy
•    MR guided radiotherapy
•    Hypofractionation and radiosurgery
•    AI / Machine learning / Big data
•    Adaptive therapy
•    Clinical trials
•    Strategic, policy and workforce issues
•    Radiotherapy errors and challenges
•    Engineering / IT / Infrastructure
•    Manufacturers presentations

View event programme

Expert teaching sessions will be held at the end of day one, and the start of day two, to provide targeted educational opportunities in areas such as IGRT, dosimetry and detectors, particle therapy and adaptive therapy. Sessions are also earmarked for proffered material in the form of oral presentations, and other material will be accepted in the form of ePosters and short YouTube clips. All-in-all, the best in radiotherapy and oncology will be featured at this new meeting!

Who should attend?  
You! If you’re working in radiotherapy and oncology, then this meeting is designed for you – and that is for all disciplines. The BIR is rapidly becoming the home of ALL professionals involved with radiotherapy and oncology and is open to all. So, clinical oncologists, radiographers, physicists, service managers, Linac and IT engineers, dosimetrists, manufacturers, department heads…all are welcome, and there should be something for everyone.

Call for abstracts
We invite professionals and researchers to submit abstracts (up to 400 words) for:

  • Oral presentations
  • ePosters
  • Short (10 mins max) YouTube presentations
  • Keynote (30 min max) YouTube presentations 

relating to any of the key topic areas noted above. Material from all disciplines working in radiotherapy and oncology is invited and encouraged - all play a part in the treatment of our patients, all have a voice to be heard in our practice and its development. We would especially encourage and welcome research, case reports and review articles on all aspects of how COVID-19 has affected our clinical, technical and professional practice in radiotherapy and oncology. Two specific sessions have been earmarked for proffered oral presentations; digital screens will be available for poster viewing in the conference venue and YouTube clips will be uploaded onto the BIR website for access by meeting delegates throughout the meeting.

Submit here by 5pm Sunday 15 November 2020

Exhibit at BIRARTO 2021

The 'BIR Annual Radiotherapy and Oncology meeting 2021' event offers sponsors and exhibitors an excellent opportunity to reach out to a large number of multidisciplinary medical professionals in a relaxed environment along with an opportunity to choose a speaker of your choice to speak at the event. View our exhibiting and sponsorship brochure for all the packages on offer!

To secure sponsorship, please complete and return the Booking form to:


Registration Fees



BIR / IAMP Member Plan 1 £155

BIR Member Plan 2 £105

BIR / IAMP Trainee member £105

BIR / IAMP Retired £55

BIR / IAMP Student member £55

BIR / IAMP Non member £250


BIR / IAMP Member Plan 1 £250

BIR Member Plan 2 £190

BIR / IAMP Trainee member £190

BIR / IAMP Retired £95

BIR / IAMP Student member £95

BIR / IAMP Non member £385


BIR / IAMP Member Plan 1 £185

BIR Member Plan 2 £125

BIR / IAMP Trainee member £125

BIR / IAMP Retired £65

BIR / IAMP Student member £65

BIR / IAMP Non member £295



BIR / IAMP Member Plan 1 £295

BIR Member Plan 2 £220

BIR / IAMP Trainee member £220

BIR / IAMP Retired £110

BIR / IAMP Student member £110

BIR / IAMP Non member £450

*Early bird rates expire on Sunday 17 January 2021

Registration information
Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees, we advise them to fill out the event registration form and return to Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email

Photography disclaimer 

The British Institute of Radiology may take photos at events. These images will be used by the BIR to share news about the event and to publicise upcoming events. Images may be used in press releases, printed publicity and published on the website and social media. They will be stored securely, and will be deleted after they are no longer needed for publicity purposes. 


Please note, by registering for a BIR event you are giving consent for your photo to be used by the BIR for marketing and publicity purposes. If you would prefer not to be photographed, please email the BIR events team or speak to a member of staff on the day.





Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:


Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Oncology Systems Limited

Since 1999, OSL has continuously grown to become a trusted independent provider of medical equipment and software to the NHS and private hospitals in the UK, Ireland and worldwide. Our team comprises of clinically and scientifically qualified radiation therapists, medical physicists, and imaging scientists, giving us the expertise to manufacture and distribute state-of-the-art radiotherapy equipment. Our equipment includes innovative patient positioning solutions, advanced secondary check software for SABR implementation, hardware, and software to enable the MR planning pathway in radiotherapy, as well as a wide range of products to automate and streamline radiotherapy treatment and quality assurance. Our products are cutting edge and innovative, and our support is delivered by experts, ultimately enabling clinicians to provide the highest quality therapies for the treatment of cancer. For more information please visit

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

RaySearch UK Limited

ADVANCING CANCER TREATMENT RaySearch is a committed pioneer of oncology software. Since 2000, we have worked in close cooperation with leading cancer centers to improve life and outcomes for patients. Our relentless drive to do things better leads us to ever-higher performance, accuracy, safety and usability. We believe software is the driving force for innovation in oncology today. Our systems use groundbreaking automation and machine learning to create new possibilities. RayCare®*, the next-generation oncology information system, will enable one workflow for all oncology disciplines. RayStation® harmonizes treatment planning, providing one point of control for all planning needs—any equipment, any scale.

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit